Chronic acquired demyelinating polyneuropathies.
Several entities can be put under the heading of chronic acquired demyelinating polyneuropathy. Future research will hopefully provide a greater understanding of pathophysiology, which may suggest the ideal way to classify and manage these patients. In the meantime, it is reasonable and useful to use clinical, laboratory, and electrodiagnostic data to classify patients in ways that facilitate identification and treatment. This article outlines an approach to the diagnosis and management of chronic acquired demyelinating polyneuropathies.
Saperstein
David S
DS
Phoenix Neurological Associates, 1331 North 7th Street, Suite 350, Phoenix, AZ 85006, USA. david.saperstein@gmail.com
D001369:Axons / Q000276:immunology / Q000473:pathology; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D015897:Comorbidity; D003937:Diagnosis, Differential; D004568:Electrodiagnosis / Q000379:methods / Q000592:standards; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000592:standards; D010525:Peripheral Nerves / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis* / Q000503:physiopathology* / Q000628:therapy
D002556:Cerebrospinal Fluid Proteins